Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_assertion type Assertion NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_head.
- NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_assertion description "[Analyses obtained with 164 lymph nodes from patients free of cancer and 15 nodes harboring metastases established a threshold for metastatic disease of approximately 200 GCC mRNA copies/mug total RNA, with a sensitivity of 93% and specificity of 97%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_provenance.
- NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_assertion evidence source_evidence_literature NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_provenance.
- NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_assertion SIO_000772 16899600 NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_provenance.
- NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_assertion wasDerivedFrom befree-20150227 NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_provenance.
- NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_assertion wasGeneratedBy ECO_0000203 NP442209.RASnUs9KgVipTRghIgisLN08a7IrWV7-_MjSZTnNcoUwQ130_provenance.